The 25-Hydroxy Vitamin D test runs on Roche's Cobas I 601 analyzer and is the first in Roche's pipeline for the Cobas Mass Spec solution.

Against the backdrop of a reverse stock split to get back in compliance with Nasdaq's listing requirements, the firm said that it remains on solid operational footing.